Skip to main content
Have a personal or library account? Click to login
Use of sulphonylurea in type 2 diabetes mellitus and incident risk of Hepatocellular Carcinoma: Are we safe to prescribe? Cover

Use of sulphonylurea in type 2 diabetes mellitus and incident risk of Hepatocellular Carcinoma: Are we safe to prescribe?

Open Access
|Dec 2022

Authors

P. Dissanayake

preethidis88@gmail.com

National Hospital of Sri Lanka

U. N. Wijenayake

umeshawijenayake@gmail.com

National Hospital of Sri Lanka

C. Dematapitiya

chinthanadematapitiya@yahoo.com

National Hospital of Sri Lanka

S. Pathmanathan

psivatharshya@gmail.com

National Hospital of Sri Lanka

M. Sumanatilleke

manilkasumana@gmail.com

National Hospital of Sri Lanka

U. Bulugahapitiya

udithakaush@googlemail.com

National Hospital of Sri Lanka
Language: English
Page range: 45 - 52
Published on: Dec 8, 2022
Published by: Sri Lanka College of Endocrinologists
In partnership with: Paradigm Publishing Services

© 2022 P. Dissanayake, U. N. Wijenayake, C. Dematapitiya, S. Pathmanathan, M. Sumanatilleke, U. Bulugahapitiya, published by Sri Lanka College of Endocrinologists
This work is licensed under the Creative Commons Attribution 4.0 License.